Displaying items 25-36 of 551
» View baltimoresun.com items only
< Previous
•
1
2
3
4
5
6
7
8
9
10
11-46
•
Next >
-
US STOCKS SNAPSHOT-Wall St ends higher in late rebound
ReutersNEW YORK, June 3 (Reuters) - U.S. stocks rose on Monday as weaker-than-expected factory activity last month supported views that the Federal Reserve will need to keep economic stimulus in place, while gains in Merck & Co's lifted drug companies. Intel...Tags: NASDAQ, Stock Activities, S&P 500, Nasdaq Composite, Financial Markets
-
Wall Street cierra en alza por repunte cerca de final de sesión
ReutersNUEVA YORK, 3 jun (Reuters) - Las acciones estadounidenses subieron el lunes ya que un dato de actividad manufacturera más débil de lo esperado del mes pasado apoyó las visiones de que la Reserva Federal necesitará mantener el estÃmulo económico....Tags: NASDAQ, Nasdaq Composite, Intel Corp., Stock Market
-
GLOBAL MARKETS-Stocks gain, dollar down; U.S. manufacturing slips
Reuters* Contraction in U.S. manufacturing is first in six months * Dollar falls below 100 yen, lowest since early May * Stocks first fall on weak U.S. data but later recover as investors assess QE outlook NEW YORK, June 3 (Reuters) - Stocks rose but the U.S....Tags: Petroleum Industry, NASDAQ, Stock Activities, Champaign (Champaign, Illinois), Commodity Markets
-
Wall Street cierra en alza por visiones estÃmulo Fed, suba acciones de Merck
ReutersNUEVA YORK, 3 jun (Reuters) - Las acciones estadounidenses subieron el lunes ya que un dato de actividad manufacturera más débil de lo esperado del mes pasado apoyó las visiones de que la Reserva Federal necesitará mantener el estÃmulo económico,...Tags: NASDAQ, S&P 500, Nasdaq Composite, Financial Markets, Intel Corp.
-
U.S. RESEARCH ROUNDUP: Intel, Google, Bristol, Halliburton, Akamai
ReutersJune 3 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including CME and TripAdvisor, on Monday. HIGHLIGHTS * Google Inc : Cantor Fitzgerald raises price target to $1030 from $900 *...Tags: Petroleum Industry, BioMarin Pharmaceutical Incorporated, Mortgages, New Gold Incorporated, CME Group Inc.
-
NYMEX-Oil eases after dollar-led rebound, holds above $93/bbl
ReutersTOKYO, June 4 (Reuters) - U.S. oil edged lower on Tuesday but held above $93 per barrel, as worries about slack demand weighed on prices after a late rebound the previous day on a slump in the dollar. FUNDAMENTALS * NYMEX crude for July delivery was...Tags: Petroleum Industry, Upstream Oil and Gas Activities, Ecuador, Foreign Exchange Market, North Sea
-
US STOCKS SNAPSHOT - Dow hits session highs, Merck rallies
ReutersNEW YORK, June 3 (Reuters) - U.S. stocks rose on Monday, with the Dow rising to a session high on strength in blue chip names. Merck & Co was one of the top advancers of the day, up 4.9 percent to $48.96 following the results of a melanoma drug study....Tags: Stock Activities, S&P 500, Nasdaq Composite, Financial Markets, Intel Corp.
-
Dow Jones toca máximo de sesión en Wall St
ReutersNUEVA YORK, 3 jun (Reuters) - Las acciones repuntaban el lunes en la bolsa de Nueva York y el promedio Dow Jones industrial tocó un máximo de sesión, impulsado por la subida de los pesos pesados del mercado. Las acciones de Merck & Co eran de las...Tags: S&P 500, Nasdaq Composite, Financial Markets, Intel Corp., Skin Cancer
-
GLOBAL MARKETS-Stocks, dollar slip as U.S. factory activity shrinks
Reuters* U.S. manufacturing activity contracted in May, first time in six months * Dollar falls below 100 yen NEW YORK, June 3 (Reuters) - Stocks and the dollar fell on Monday in volatile trading after a report showed U.S. manufacturing activity contracted for...Tags: Stock Activities, Foreign Exchange Market, S&P 500, Nasdaq Composite, Financial Markets
-
Roche's Avastin fails to prolong survival in brain cancer study
ReutersBy Bill Berkrot June 2 (Reuters) - The widely used Roche Holding AG cancer drug Avastin failed to prolong survival when added to chemo-radiation therapy for glioblastoma - a fast-growing type of brain tumor - according to data presented on Sunday....Tags: High Blood Pressure, Oncology, Bevacizumab (drug), Cancer, Food and Drug Administration
-
Merck KGaA's Erbitux beats Avastin in bowel cancer trial
ReutersFRANKFURT, June 1 (Reuters) - Merck KGaA's cancer drug Erbitux was shown to be more effective at prolonging the lives of bowel cancer patients than Roche's Avastin, Merck said. In a drug trial, the two drugs were each given in combination with Folfiri...Tags: Bristol Myers Squibb Company, Lilly Eli & Co, Oncology, Bevacizumab (drug), Biotechnology
-
PRESS DIGEST-New York Times business news - May 31
ReutersMay 31 (Reuters) - The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy. * After several deadly factory disasters in Bangladesh, Obama administration...Tags: Januvia (drug), Pancreatic Cancer, The New York Times, Passenger Cars, Drugs and Medicines
Jun 3, 2013
|Story| Reuters
Jun 3, 2013
|Story| Reuters
Jun 3, 2013
|Story| Reuters
Jun 3, 2013
|Story| Reuters
Jun 3, 2013
|Story| Reuters
Jun 3, 2013
|Story| Reuters
Jun 3, 2013
|Story| Reuters
Jun 3, 2013
|Story| Reuters
Jun 3, 2013
|Story| Reuters
Jun 2, 2013
|Story| Reuters
Jun 1, 2013
|Story| Reuters
May 30, 2013
|Story| Reuters
Original site for Merck & Company Incorporated topic gallery.
